119 related articles for article (PubMed ID: 21345506)
1. School accountability laws and the consumption of psychostimulants.
Bokhari FA; Schneider H
J Health Econ; 2011 Mar; 30(2):355-72. PubMed ID: 21345506
[TBL] [Abstract][Full Text] [Related]
2. Who receives a diagnosis of attention-deficit/ hyperactivity disorder in the United States elementary school population?
Schneider H; Eisenberg D
Pediatrics; 2006 Apr; 117(4):e601-9. PubMed ID: 16585277
[TBL] [Abstract][Full Text] [Related]
3. State Variation in Increased ADHD Prevalence: Links to NCLB School Accountability and State Medication Laws.
Fulton BD; Scheffler RM; Hinshaw SP
Psychiatr Serv; 2015 Oct; 66(10):1074-82. PubMed ID: 26030315
[TBL] [Abstract][Full Text] [Related]
4. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
5. Measuring inappropriate medical diagnosis and treatment in survey data: The case of ADHD among school-age children.
Evans WN; Morrill MS; Parente ST
J Health Econ; 2010 Sep; 29(5):657-73. PubMed ID: 20739076
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
[TBL] [Abstract][Full Text] [Related]
7. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
8. ADHD treatment and academic performance: a case series.
McCormick LH
J Fam Pract; 2003 Aug; 52(8):620-4, 626. PubMed ID: 12899816
[TBL] [Abstract][Full Text] [Related]
9. Are stimulants overprescribed? Treatment of ADHD in four U.S. communities.
Jensen PS; Kettle L; Roper MT; Sloan MT; Dulcan MK; Hoven C; Bird HR; Bauermeister JJ; Payne JD
J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):797-804. PubMed ID: 10405496
[TBL] [Abstract][Full Text] [Related]
10. Attention-deficit hyperactivity disorder.
Calis KA; Grothe DR; Elia J
Clin Pharm; 1990 Aug; 9(8):632-42. PubMed ID: 1974836
[TBL] [Abstract][Full Text] [Related]
11. The impact of stimulants on a clinical measure of attention in children with ADHD.
Gardner BK; Sheppard DM; Efron D
Child Neuropsychol; 2008 Mar; 14(2):171-86. PubMed ID: 17852126
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
Yang P; Hsu HY; Chiou SS; Chao MC
Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
[TBL] [Abstract][Full Text] [Related]
13. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.
Levin H; Hanten G; Max J; Li X; Swank P; Ewing-Cobbs L; Dennis M; Menefee DS; Schachar R
J Dev Behav Pediatr; 2007 Apr; 28(2):108-18. PubMed ID: 17435461
[TBL] [Abstract][Full Text] [Related]
14. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
15. [Better health care for children and adolescents with attention deficit hyperactivity disorder].
Klasen H; Verhulst FC
Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1723-5. PubMed ID: 16114286
[TBL] [Abstract][Full Text] [Related]
16. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
Bricard C; Boidein F
Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
[TBL] [Abstract][Full Text] [Related]
17. Visual fields in children with attention-deficit / hyperactivity disorder before and after treatment with stimulants.
Martin L; Aring E; Landgren M; Hellström A; Andersson Grönlund M
Acta Ophthalmol; 2008 May; 86(3):259-64. PubMed ID: 18494726
[TBL] [Abstract][Full Text] [Related]
18. The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review.
Erenberg G
Semin Pediatr Neurol; 2005 Dec; 12(4):217-21. PubMed ID: 16780292
[TBL] [Abstract][Full Text] [Related]
19. Are there placebo effects in the medication treatment of children with attention-deficit hyperactivity disorder?
Waschbusch DA; Pelham WE; Waxmonsky J; Johnston C
J Dev Behav Pediatr; 2009 Apr; 30(2):158-68. PubMed ID: 19363369
[TBL] [Abstract][Full Text] [Related]
20. A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.
Biederman J; Wigal SB; Spencer TJ; McGough JJ; Mays DA
Clin Ther; 2006 Feb; 28(2):280-93. PubMed ID: 16678649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
